Cardiovascular Disease Rates Fuel Expansion Of POC Coagulation Testing Market: An Emerging Driver Transforming The Point-of-Care (POC) Coagulation Testing Market Landscape

The Point-of-Care (POC) Coagulation Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Point-of-Care (POC) Coagulation Testing Market?
The market size of point-of-care (POC) coagulation testing has seen significant growth in the past few years. The size is expected to increase from $1.18 billion in 2024 to $1.25 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The previous growth can be linked to factors such as increased patient demand, a rising trend in point-of-care testing, the high accuracy of coagulation status on PT tests, automation, integration with electronic health records (EHRs), and a higher incidence of cardiovascular diseases and blood disorders.

The market size for point-of-care (POC) coagulation testing is anticipated to experience consistent growth in the coming years, escalating to $1.48 billion by 2029 with a compound annual growth rate (CAGR) of 4.2%. The forecasted growth can be explained by the wider applications in healthcare, an increase in demand within homecare environments, a rise in the incidence of chronic blood diseases, patient preference for speedy and precise testing, and growth of point-of-care testing. Notable trends for the forecast period include technological progress, amplified demand within developed nations, extension of healthcare applications, the impact of COVID-19, and the incorporation of multiple tests in POC diagnostics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913

What Are the Different Point-of-Care (POC) Coagulation Testing Market Segments?
The point-of-care (POC) coagulation testing market covered in this report is segmented -

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care

Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

What Are the Primary Drivers Shaping the Point-of-Care (POC) Coagulation Testing Market?
The escalating prevalence of cardiovascular illnesses is anticipated to drive the expansion of the market for point-of-care (POC) coagulation testing. Cardiovascular diseases (CVDs) encompass a variety of heart and blood vessel disorders such as coronary artery disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation testing, which gives immediate insights into clotting status, aids in the management of CVDs by facilitating prompt decision-making for coagulation treatments and lowering the likelihood of post-surgery haemorrhaging. In October 2022, the Switzerland-based NGO World Heart Federation released a report predicting a rise in CVD-related mortalities, expected to increase from approximately 18.9 million in 2020 to over 22.2 million by 2030, and to 32.3 million by 2050. This growing prevalence of cardiovascular illnesses is therefore fueling the expansion of the POC coagulation testing market.

Which Companies Are Leading in the Point-of-Care (POC) Coagulation Testing Market?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

What Are the Major Trends Shaping the Point-of-Care (POC) Coagulation Testing Market?
Major firms engaged in the point-of-care (POC) coagulation testing market are focusing on strategic alliances to secure a competitive advantage. These strategic alliances are formal agreements between two or more entities aiming to achieve shared goals that yield mutual benefits. For example, in January 2023, US-based company Jana care, known for creating biomarker assays for its unique digital health application, entered into a partnership with Switzerland-based Roche Diagnostics, a developer of diagnostic tests, tools, and digital healthcare solutions. Their shared objective is to create and distribute a point-of-care platform for blood testing aimed at screening for chronic kidney disease and heart failure. This state-of-the-art platform will allow patients to conduct blood tests from home while remote clinicians review the results.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the Point-of-Care (POC) Coagulation Testing Market?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market?
2. What is the CAGR expected in the Point-of-Care (POC) Coagulation Testing Market?
3. What Are the Key Innovations Transforming the Point-of-Care (POC) Coagulation Testing Industry?
4. Which Region Is Leading the Point-of-Care (POC) Coagulation Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.